Construction of chimera PRRSV, compositions and vaccine preparations

A composition and replicon technology, applied in the field of molecular virology, can solve problems such as no cross protection

Inactive Publication Date: 2009-06-10
PROTATEK INT
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, conventional vaccines do not cross-protect against

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction of chimera PRRSV, compositions and vaccine preparations
  • Construction of chimera PRRSV, compositions and vaccine preparations
  • Construction of chimera PRRSV, compositions and vaccine preparations

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Example 1. Addition of genetic marker sequences in infectious non-virulent PRRSV clones.

Embodiment 2

[0035] Example 2. Subcloning of the 5' sequence (13117 bp) of an avirulent strain of PRRSV in pBluescript SK(+).

Embodiment 3

[0036] Example 3. Subcloning of the 3' sequence of a wild isolate of PRRSV in the vector pCR-Blunt.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Chimeric replicons of North American Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) containing the 5' sequence of an avirulent strain of PRRSV and a 3' sequence of a virulent strain of PRRSV are provided. Further provided is a method of producing attenuated PRRSVfrom the chimeric replicon. Also provided are compositions containing the replicon or attenuated virus. Vaccines and a method of vaccinating pigs against PRRSV are also provided.

Description

technical field [0001] The present invention relates to molecular virology. In particular, the invention includes methods of attenuating the virulence of porcine reproductive and respiratory syndrome virus (PRRSV) and viral compositions comprising attenuated PRRSV. Background technique [0002] Porcine Reproductive and Respiratory Syndrome (PRRS) is the most significant disease economically affecting the swine industry, with the virus causing approximately $5.6 billion in annual losses in the United States. Primary symptoms of the disease are reproductive problems in sows and gilts, including late abortions, stillbirths and mummies, as well as small, frail piglets that are born viremic and often do not survive. In addition, symptoms in young pigs manifest as respiratory disease resulting in fever, lethargy, dyspnea, low appetite, slow growth and occasional death, often in combination with other respiratory pathogens. Semen from infected boars, whether through natural matin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/04A61K39/12
CPCC12N2770/10022C12N7/00A61K2039/525A61K2039/5258C07K14/005C12N2770/10021
Inventor X·张S·马
Owner PROTATEK INT
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products